Heart disease and women

Information

People often do not consider heart disease a woman's disease.Yet cardiovascular disease is the leading killer of women over age 25. It kills nearly twice as many women in the United States as all types of cancer.

Men have a greater risk for heart disease earlier in life than women. Women's risk increases after menopause.

EARLY HEART DISEASE SIGNS

Women may have warning signs that go unnoticed for weeks or even years a heart attack occurs.

ACT IN TIME

Recognizing and treating a heart attack right away improves your chance for survival. On average, a person having a heart attack will wait for 2 hours before calling for help.

Know the warning signs and always call 911 within 5 minutes of when symptoms begin. By acting quickly, you can limit damage to your heart.

MANAGE YOUR RISK FACTORS

A risk factor is something that increases your chance of getting a disease or having a certain health condition. You can change some risk factors for heart disease. Other risk factors you cannot change.

Women should work with their health care provider to address risk factors they can change.

Estrogen is no longer used to prevent heart disease in women of any age. Estrogen may increase the risk of heart disease for older women. However, it may still be used for some women to treat hot flashes or other medical problems.

Some women can take a low dose aspirin daily to help prevent heart attacks. Aspirin can increase the risk for bleeding, so check with your health care provider before beginning daily aspirin treatment.

LIVE A HEALTHY LIFESTYLE

Some of the risk factors for heart disease that you CAN change are:

If you drink alcohol, limit yourself to no more than one drink per day. Do not drink just for the purpose of protecting your heart.

Good nutrition is important to your heart health, and it will help control some of your heart disease risk factors.

References

Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 Feb;42(2):517-84. Epub 2010 Dec 2.

Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011 Nov 29;58(23):2432-46. Epub 2011 Nov 3.

Gaziano JM, ridker PM, Libby P. Primary and secondary prevention of coronary heart disease. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 49.

Hansson GK, Hamsten A. Atherosclerosis, thrombosis, and vascular biology. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 70.

Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: A guideline from the American Heart Association. Circulation. 2011;123(11):1243-1262.

Newby LK, Douglas PS. Cardiovascular disease in women. In: Bonow RO, Mann DL, Zipes DP, Libby P, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular MEdicine. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 81.

North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010;17:242-255.

Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;150(6):405-410.